力成药业

R&D platforms

Starting from the RD of inhalation formulations, Leecan Pharmaceutical Research Institute has been breaking through the barriers of complicated formulation RD; focusing on the RD and industrialization of inhalation formulations, sustained and controlled release formulations, complicated injections and innovative formulations; and possessing the rich experience in the core technology of the whole industrial chain from the selection of projects, drug design, quality research, clinical research and industrialization. The RD laboratory of the research institute covers an area of more than 6,000 square feet, with more than 300 sets of RD equipment, supporting more than 10 GMP production lines for transformation; all the RD staff, adhering to the core values of ‘Integrity, Pragmatism, Innovation, Endeavour’, will gradually enrich the RD pipeline and therapeutic areas by combining imitation with invention, in order to satisfy patients' clinical needs. To meet the clinical needs of many patients, we will contribute to the health of China.

Inhalation formulation platforms

Focus on asthma, COPD, expectoration, persistent cough, pulmonary fibrosis, and lung infections.

Sustained and controlled release formulation platforms

Focus on psychiatric diseases, autoimmunity, and chronic inflammation.

Complicated injection platforms

Focus on antineoplastic, psychiatric disorders and autoimmunity.

Innovative formulation platforms

Focusing on the clinical unmet needs in the fields of anti-tumour and psychiatric system diseases, we will seek clinical advantages of the established varieties and continuously improve the company's innovation capability.

Production and Operations

Pharmaceuticals and Health Industry advanced Inhalation Preparation and Complicated Preparation Production Base

Inhalation formulations ‘research, production and marketing’ integrated production base - Nanjing

Located in Building 9 of Accelerator VI, No.71 Xinghui Road, Jiangbei New District, Nanjing, with a total area of 13,189.01 square meters for a single building and a plant area of 2,050.24 square meters, it has built three preparation workshops, with the main products of inhalation liquid preparation and inhalation powder, and a designed annual production capacity of about 450 million liquid preparations and 450 million powders for inhalation.

Production base for advance inhalation and compllicated formulations – Hefei

Located at No.29 Gaocheng Road, Economic Development Zone, Feixi County, Hefei City, with a building area of about 131,200 square metres, the company is designed to build 14 workshops. The production lines cover a wide range of dosage forms such as injections, pre-filled needles, aerosols, solid preparations, etc., with a production capacity of 29 million bottles for advanced inhalation preparations and 34,000,000 tablets (granules) for complicated preparations. All production lines are carefully designed with a high level of automation and intelligence to ensure that the quality of drugs in the production process is safe, effective, and quality-controlled.

EHS Management System

Leecan Pharmaceuticals pays attention to the health and safety of employees, environmental protection and the fulfilment of social responsibility, establishes a sound EHS management system, complies with laws, regulations and ethical norms in the management of environment, safety and occupational health, ensures that the company's behaviour meets the requirements of industry norms, and enhances the competitiveness of the company.

Cleaner production

In strict accordance with the relevant requirements of the Cleaner Production Promotion Law of the People's Republic of China, we carry out cleaner production work in the spirit of ‘energy saving, consumption reduction, pollution reduction and efficiency enhancement’ to reduce pollution from the source and improve the efficiency of resource utilisation

Quality Management

We control every step of the pharmaceutical process with our heart, so that every patient can use our medicines with confidence.

Standardised management, quality first

Pursuing excellence and enhancing quality

Leecan Pharmaceuticals has always adhered to the mission of ‘science and technology to improve the quality of life’, with the vision of ‘a century of Leecan, blessing health’, practicing the core values of ‘Integrity, Pragmatism, Innovation, Endeavor’, and promoting the quality culture of “reassuring ourselves, reassuring patients, reassuring the supervision and reassuring the society”. to providing safe, high-quality, and efficient medicines to the society.

The company has established a rigorous quality management system in accordance with EU GMP and US FDA cGMP regulations and has implemented the strictest control over each step of the production and inspection process in strict accordance with the requirements of the registered and approved processes and management procedures. From the selection of API and excipient suppliers to the monitoring of the entire production process and the product release of the products on the market, we always adhere to the principle of data reliability, make the most objective and accurate evaluation of the quality of each batch of drugs with the strictest standards and the truest data, and ensure that each link of the production and testing process undergoes strict verification procedure to guarantee the quality of each batch of products in a sustainable and stable manner.

CMO/CDMO

CMO/CDMO services

Leecan Pharmaceuticals integrates the resources of production and research platforms to provide efficient, flexible, and high-quality CMO/CDMO services for the pharmaceutical science industry, covering R&D, production, R&D/production, and registration.